Christine Lasich
Nurse Practitioner · Portland, ORNPI 1649799032
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Abiomed at 42.9% of the total. 2025 is the largest year on record at $862, more than ten times the $51 reported in 2021. Among nurse practitioner clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 66 payments — averaging $36.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$1K
- Atricure, Inc.$247
- Baxter Healthcare$194
- AbbVie$119
- Getinge USA Sales, LLC$112
- AstraZeneca$112
- plus $582 from 13 others
What the payments were for
- Food & beverage$2,391100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 29 | $1,025 |
| Atricure, Inc. | 7 | $247 |
| Baxter Healthcare | 5 | $194 |
| AbbVie | 2 | $119 |
| Getinge USA Sales, LLC | 3 | $112 |
| AstraZeneca | 4 | $112 |
| Arthrex | 1 | $106 |
| Intuitive Surgical | 1 | $100 |
| Medtronic | 2 | $61 |
| Johnson & Johnson | 1 | $49 |
| Merck | 2 | $47 |
| Medical Device Business Services, Inc. | 1 | $40 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $38 |
| Edwards Lifesciences | 1 | $33 |
| Left Coast Surgical Inc | 1 | $27 |
| Solventum Corporation | 1 | $25 |
| Abbott | 1 | $24 |
| Octapharma USA, Inc. | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$250
How this compares
$2,391 in reported general payments places this provider in the 95th percentile of 997 nurse practitioner providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 51 | $473 |
| Rosuvastatin Calcium | 13 | $371 |
| Metoprolol Tartrate | 24 | $134 |
| Oxycodone Hcl | 20 | $75 |
| Methocarbamol | 13 | $74 |
| Gabapentin | 14 | $69 |
| Potassium Chloride | 13 | $41 |
| Tramadol Hcl | 17 | $24 |
| Furosemide | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Portland
- Alana WilsonPortland$58K
- Jennifer MurdochPortland$15K
- Berhane MebratuPortland$10K
- Amy CarterPortland$8K
- Craig SchultzPortland$6K
- Megha ManandharPortland$3K
- Alicia DuyvejonckSpringfield$299K
- Summer HarnessLake Oswego$113K
- Desiree CihelkaSpringfield$8K
- Margaret McLainCoos Bay$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.